These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33527850)

  • 1. Discerning the role of polymicrobial biofilms in the ascent, prevalence, and extent of heteroresistance in clinical practice.
    Lopes SP; Jorge P; Sousa AM; Pereira MO
    Crit Rev Microbiol; 2021 Mar; 47(2):162-191. PubMed ID: 33527850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global priority pathogens: virulence, antimicrobial resistance and prospective treatment options.
    M Campos JC; Antunes LC; Ferreira RB
    Future Microbiol; 2020 May; 15():649-677. PubMed ID: 32495702
    [No Abstract]   [Full Text] [Related]  

  • 3. Biofilm is a Major Virulence Determinant in Bacterial Colonization of Chronic Skin Ulcers Independently from the Multidrug Resistant Phenotype.
    Di Domenico EG; Farulla I; Prignano G; Gallo MT; Vespaziani M; Cavallo I; Sperduti I; Pontone M; Bordignon V; Cilli L; De Santis A; Di Salvo F; Pimpinelli F; Lesnoni La Parola I; Toma L; Ensoli F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance three ways: healthcare crisis, major concepts and the relevance of biofilms.
    Jorge P; Magalhães AP; Grainha T; Alves D; Sousa AM; Lopes SP; Pereira MO
    FEMS Microbiol Ecol; 2019 Aug; 95(8):. PubMed ID: 31305896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm.
    Soto SM
    Virulence; 2013 Apr; 4(3):223-9. PubMed ID: 23380871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of biofilm stimulation by subinhibitory concentrations of antimicrobials.
    Ranieri MR; Whitchurch CB; Burrows LL
    Curr Opin Microbiol; 2018 Oct; 45():164-169. PubMed ID: 30053750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic treatment of biofilm infections.
    Ciofu O; Rojo-Molinero E; Macià MD; Oliver A
    APMIS; 2017 Apr; 125(4):304-319. PubMed ID: 28407419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview perspective of bacterial resistance.
    Furtado GH; Nicolau DP
    Expert Opin Ther Pat; 2010 Oct; 20(10):1273-6. PubMed ID: 20687782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria.
    Kester JC; Fortune SM
    Crit Rev Biochem Mol Biol; 2014; 49(2):91-101. PubMed ID: 24328927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biofilm-associated infections: antibiotic resistance and novel therapeutic strategies.
    Sun F; Qu F; Ling Y; Mao P; Xia P; Chen H; Zhou D
    Future Microbiol; 2013 Jul; 8(7):877-86. PubMed ID: 23841634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biofilm-specific antibiotic tolerance and resistance.
    Olsen I
    Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):877-86. PubMed ID: 25630538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial heteroresistance: an emerging field in need of clarity.
    El-Halfawy OM; Valvano MA
    Clin Microbiol Rev; 2015 Jan; 28(1):191-207. PubMed ID: 25567227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of treating biofilm-associated bacterial infections.
    del Pozo JL; Patel R
    Clin Pharmacol Ther; 2007 Aug; 82(2):204-9. PubMed ID: 17538551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Resistance in ESKAPE Pathogens.
    De Oliveira DMP; Forde BM; Kidd TJ; Harris PNA; Schembri MA; Beatson SA; Paterson DL; Walker MJ
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biofilm-related disease.
    Del Pozo JL
    Expert Rev Anti Infect Ther; 2018 Jan; 16(1):51-65. PubMed ID: 29235402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial resistance in biofilm-associated bacteria.
    Venkatesan N; Perumal G; Doble M
    Future Microbiol; 2015; 10(11):1743-50. PubMed ID: 26517598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biofilms of pathogenic bacteria and their role in chronization of infectious process. The search for the means to control biofilms].
    Romanova IuM; Didenko LV; Tolordava ÉR; Gintsburg AL
    Vestn Ross Akad Med Nauk; 2011; (10):31-9. PubMed ID: 22168037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical countermeasures for the control of bacterial biofilms: effective compounds and promising targets.
    Musk DJ; Hergenrother PJ
    Curr Med Chem; 2006; 13(18):2163-77. PubMed ID: 16918346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
    Mao T; Zhai H; Duan G; Yang H
    Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Emergence of High Persistence upon Periodic Aminoglycoside Challenge in the ESKAPE Pathogens.
    Michiels JE; Van den Bergh B; Verstraeten N; Fauvart M; Michiels J
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4630-7. PubMed ID: 27185802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.